in may 1972 , the cancer and leukemia group b initiated a randomized study comparing the effectiveness of ccnu and methyl-ccnu in patients with advanced malignant lymphomas , including hodgkin 's disease ( hd ) , lymphosarcoma ( lys ) and reticulum cell sarcoma ( rcs ) .
C0006826
cancer
C0024299
lymphosarcoma